553008

Raf1 Kinase Inhibitor I

The Raf1 Kinase Inhibitor I, also referenced under CAS 220904-83-6, controls the biological activity of Raf1 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

• 同義詞: Raf1 Kinase Inhibitor I, 5-Iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone, GW 5074
• 經驗公式（希爾表示法）: C₁₅H₈Br₂INO₂
• CAS號碼: 220904-83-6
• 分子量：: 520.94
• MDL號碼: MFCD03453076
• 分類程式碼代碼: 12352200
• NACRES: NA.28

屬性

• 品質等級: 100
• 化驗: ≥97% (HPLC)
• 形狀: solid
• 效力: 9 nM IC₅₀
• 製造商／商標名: Calbiochem^®
• 儲存條件: OK to freeze; protect from light
• 顏色: dark orange
• 溶解度: DMSO: 200 mg/mL
• 運輸包裝: ambient
• 儲存溫度: −20°C
• InChI: 1S/C15H8Br2INO2/c16-11-4-7(5-12(17)14(11)20)3-10-9-6-8(18)1-2-13(9)19-15(10)21/h1-6,20H,(H,19,21)/b10-3-
• InChI 密鑰: LMXYVLFTZRPNRV-KMKOMSMNSA-N

描述

一般說明

A potent, cell-permeable, reversible, and ATP-competitive cRAF1 kinase inhibitor (IC₅₀ = 9 nM). Shows ≥100-fold selectivity for Raf kinase versus Cdk1, Cdk2, c-Src, ERK2, MEK, p38, Tie2, VEGFR2, and c-Fms. Predicted broad spectrum antitumor agents. A 10 mM (500 µg/96 µl) solution of Raf1 Inhibitor I (Cat. No. 553003) in DMSO is also available.

A potent, cell-permeable, reversible, and ATP-competitive cRaf1 kinase inhibitor (IC₅₀ = 9 nM). Shows ≥100-fold selectivity for Raf kinase versus Cdk1, Cdk2, c-src, ERK2, MEK, p38, Tie2, VEGFR2 and c-fms. cRaf1 inhibitors are predicted to be broad spectrum antitumor agents.

生化／生理作用

Cell permeable: yes

Primary Target
CRAFI kinase

Product competes with ATP.

Reversible: yes

包裝

Packaged under inert gas

警告

Toxicity: Standard Handling (A)

重構

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.







From Catalog:

Desc. Field- added "Predicted broad spectrum antitumor agents."

其他說明

Lackey, K., et al. 2000. Bioorg. Med. Chem. Lett.10, 223.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3